MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
State of the Facilities Management Industry in 2025
Many facility managers cite budget constraints and the rise in operating concerns as their top concerns heading into the new year.
City of Hope to Open New Cancer Specialty Hospital in California
This 72-acre academic research campus offers patients access to the full continuum of advanced cancer care.
Montefiore Einstein Opening New Inpatient Center for Youth in the Bronx
New 21-bed inpatient pediatric mental health center adds critical care beds to address behavioral and mental health needs in the Bronx, nearly doubling inpatient capacity.
Skill Stacking: How Micro-Credentials Are Reshaping Trades
Micro-credentials can keep skilled trade workers up to speed with modern systems and complement longer, more formal training programs.
Prima Medicine Opens New Location in Tysons, Virginia
The Tysons location becomes Prima Medicine's fifth practice in the Washington metropolitan area.